|
Post by sla55 on Sept 1, 2017 8:06:40 GMT -5
WESTLAKE VILLAGE, Calif., Sept. 01, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD), focused on the discovery and development of therapeutic products for patients with diseases such as diabetes, announced today that it will present at upcoming conferences. Rodman & Renshaw 19th Annual Global Investment Conference on Monday, September 11, 2017 at 9:35 am (ET) at the Lotte New York Palace in New York Cantor Fitzgerald Global Healthcare Conference on Monday, September 25, 2017 at 9:10 am (ET) at the InterContinental New York Barclay Hotel in New York Presenting from the Company will be its Chief Executive Officer, Michael Castagna. Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at www.mannkindcorp.com.
|
|
|
Post by jmkopp on Sept 1, 2017 9:15:09 GMT -5
Was this what Mike was talking about in the cc? I was hoping he meant we would be talking about 2 press releases in September; maybe label change and financing or partnership.
|
|
|
Post by n8 on Sept 7, 2017 14:17:27 GMT -5
|
|